Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析

◆英語タイトル:Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2577
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kuraray Co Ltd (3405) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kuraray Co Ltd (Kuraray) is a synthetic and chemical fiber manufacturing company. It develops and commercializes chemicals, resins, fibers, high performance materials and medical products, among others. The company’s product portfolio includes vinyl acetate derivatives, isoprene derivatives, methacrylate derivatives, medical agents and eco-friendly products, besides the gas barrier material EVAL. It offers engineering, design, construction, and maintenance services for chemicals, food processing, pharmaceuticals and electronic material manufacturing facilities. Kuraray also offers resin-based dental materials, dental adhesives and cement to bond dental structures. The company manages affiliates, manufacturing facilities and research centers in countries across Asia, Europe and North America. Kuraray is headquartered in Chiyoda-ku, Tokyo, Japan.

Kuraray Co Ltd Key Recent Developments

Nov 01,2017: EVAL EVOH Resin Price Increase Announcement
Sep 12,2017: PTTGC Meets Leading Foreign Investors As It Aims To Expand Petrochemical Industry Investments In EEC
May 11,2017: kuraray Announces Consolidated Earnings Report For First Quarter Of Fiscal Year Ending December 31, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Kuraray Co Ltd – Key Facts 6
Kuraray Co Ltd – Key Employees 7
Kuraray Co Ltd – Major Products and Services 9
Kuraray Co Ltd – History 11
Kuraray Co Ltd – Company Statement 15
Kuraray Co Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 18
Section 2 – Company Analysis 19
Company Overview 19
Kuraray Co Ltd – Business Description 20
Business Segment: Fibers and Textiles 20
Overview 20
Performance 20
Business Segment: Functional Materials 20
Overview 20
Performance 21
Business Segment: Isoprene 21
Overview 21
Performance 21
Business Segment: Others 21
Overview 21
Performance 21
Business Segment: Trading 21
Overview 21
Performance 22
Business Segment: Vinyl Acetate 22
Overview 22
Performance 22
Geographical Segment: Asia 22
Performance 22
Geographical Segment: China 22
Performance 22
Geographical Segment: Europe 22
Performance 22
Geographical Segment: Japan 23
Performance 23
Geographical Segment: Other Area 23
Performance 23
Geographical Segment: United States 23
Performance 23
Kuraray Co Ltd – Corporate Strategy 24
Kuraray Co Ltd – SWOT Analysis 25
SWOT Analysis – Overview 25
Kuraray Co Ltd – Strengths 25
Kuraray Co Ltd – Weaknesses 26
Kuraray Co Ltd – Opportunities 27
Kuraray Co Ltd – Threats 28
Kuraray Co Ltd – Key Competitors 29
Section 3 – Company Financial Ratios 30
Financial Ratios – Capital Market Ratios 30
Financial Ratios – Annual Ratios 31
Performance Chart 34
Financial Performance 34
Financial Ratios – Interim Ratios 35
Financial Ratios – Ratio Charts 36
Section 4 – Company’s Petrochemicals Financial Deals and Alliances 37
Kuraray Co Ltd, Petrochemicals, Deals By Year, 2012 to YTD 2018 37
Kuraray Co Ltd, Petrochemicals, Deals By Type, 2012 to YTD 2018 38
Kuraray Co Ltd, Recent Deals Summary 39
Section 5 – Company’s Recent Developments 40
Nov 01, 2017: EVAL EVOH Resin Price Increase Announcement 40
Sep 12, 2017: PTTGC Meets Leading Foreign Investors As It Aims To Expand Petrochemical Industry Investments In EEC 41
May 11, 2017: kuraray Announces Consolidated Earnings Report For First Quarter Of Fiscal Year Ending December 31, 2017 42
Section 6 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Kuraray Co Ltd, Key Facts 6
Kuraray Co Ltd, Key Employees 7
Kuraray Co Ltd, Major Products and Services 9
Kuraray Co Ltd, History 11
Kuraray Co Ltd, Other Locations 16
Kuraray Co Ltd, Subsidiaries 17
Kuraray Co Ltd, Joint Venture 18
Kuraray Co Ltd, Key Competitors 29
Kuraray Co Ltd, Ratios based on current share price 30
Kuraray Co Ltd, Annual Ratios 31
Kuraray Co Ltd, Annual Ratios (Cont...1) 32
Kuraray Co Ltd, Annual Ratios (Cont...2) 33
Kuraray Co Ltd, Interim Ratios 35
Kuraray Co Ltd, Petrochemicals, Deals By Year, 2012 to YTD 2018 37
Kuraray Co Ltd, Petrochemicals, Deals By Type, 2012 to YTD 2018 38
Kuraray Co Ltd, Recent Deals Summary 39
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List of Figures
Kuraray Co Ltd, Performance Chart (2013 - 2017) 34
Kuraray Co Ltd, Ratio Charts 36
Kuraray Co Ltd, Petrochemicals, Deals By Year, 2012 to YTD 2018 37
Kuraray Co Ltd, Petrochemicals, Deals by Type, 2012 to YTD 2018 38

★海外企業調査レポート[Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catholic University of Leuven:製薬・医療:M&Aディール及び事業提携情報
    Summary Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, …
  • Genting Plantations Berhad (GENP):企業の財務・戦略的SWOT分析
    Genting Plantations Berhad (GENP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報
    Summary Sopharma AD (Sopharma) develops, manufactures and commercializes medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposab …
  • Piramal Enterprises Ltd (PEL):企業の財務・戦略的SWOT分析
    Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PT Indo Tambangraya Megah Tbk:企業の戦略・SWOT・財務情報
    PT Indo Tambangraya Megah Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Indo Tambangraya Megah Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Life Insurance Corporation of India:企業の戦略的SWOT分析
    Life Insurance Corporation of India - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Thaivivat Insurance Public Company Limited
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Nova Eye Medical Ltd (EYE):企業の財務・戦略的SWOT分析
    Nova Eye Medical Ltd (EYE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Veidekke ASA (VEI):企業の財務・戦略的SWOT分析
    Veidekke ASA (VEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • HOV Services Ltd (HOVS):企業の財務・戦略的SWOT分析
    HOV Services Ltd (HOVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Helius Medical Technologies Inc (HSM):企業の製品パイプライン分析2018
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of tec …
  • Natera Inc (NTRA):企業の製品パイプライン分析2018
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Gemalto N.V. (GTO):企業の財務・戦略的SWOT分析
    Gemalto N.V. (GTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Greenleaf Power LLC:電力:M&Aディール及び事業提携情報
    Summary Greenleaf Power LLC (Greenleaf Power) is a provider of renewable energy services in North America. The company acquires and operates base-load biomass plants to generate electricity. It collects residual biomass material from agricultural, construction, demolition, landfill, and timber indus …
  • Valiant Holding AG:企業の戦略・SWOT・財務分析
    Valiant Holding AG - Strategy, SWOT and Corporate Finance Report Summary Valiant Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. The company develops products using its proprietary peripheral arterial tonomet …
  • Inform Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …
  • GamaMabs Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company that develops optimized therapeutic antibodies for the treatment of cancer. The company’s lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mulleri …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Mitochon Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotech company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products comprise mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stroke, h …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆